200 related articles for article (PubMed ID: 29703480)
1. Arterial thrombosis and cancer.
Aronson D; Brenner B
Thromb Res; 2018 Apr; 164 Suppl 1():S23-S28. PubMed ID: 29703480
[TBL] [Abstract][Full Text] [Related]
2. Arterial Thrombosis in Cancer Patients: An Update.
Franchini M; Tufano A; Casoria A; Coppola A
Semin Thromb Hemost; 2021 Nov; 47(8):942-949. PubMed ID: 34464985
[TBL] [Abstract][Full Text] [Related]
3. Surviving Cancer without a Broken Heart.
Caspi O; Aronson D
Rambam Maimonides Med J; 2019 Apr; 10(2):. PubMed ID: 31002639
[TBL] [Abstract][Full Text] [Related]
4. Arterial Thrombosis in Patients with Cancer.
Tuzovic M; Herrmann J; Iliescu C; Marmagkiolis K; Ziaeian B; Yang EH
Curr Treat Options Cardiovasc Med; 2018 Apr; 20(5):40. PubMed ID: 29627870
[TBL] [Abstract][Full Text] [Related]
5. Risk of arterial thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: an up-to-date meta-analysis.
Qi WX; Shen Z; Tang LN; Yao Y
Crit Rev Oncol Hematol; 2014 Nov; 92(2):71-82. PubMed ID: 24878433
[TBL] [Abstract][Full Text] [Related]
6. Major adverse cardiovascular events associated with VEGF-targeted anticancer tyrosine kinase inhibitors: a real-life study and proposed algorithm for proactive management.
Vallerio P; Orenti A; Tosi F; Maistrello M; Palazzini M; Cingarlini S; Colombo P; Bertuzzi M; Spina F; Amatu A; Lombardo R; Prata I; Scaglione F; Vighi GD; Severgnini B; Siena S; Giannattasio C; Boracchi P; Sartore-Bianchi A
ESMO Open; 2022 Feb; 7(1):100338. PubMed ID: 34920290
[TBL] [Abstract][Full Text] [Related]
7. The prothrombotic activity of cancer cells in the circulation.
Mitrugno A; Tormoen GW; Kuhn P; McCarty OJ
Blood Rev; 2016 Jan; 30(1):11-9. PubMed ID: 26219246
[TBL] [Abstract][Full Text] [Related]
8. Arterial Thrombosis in Cancer: Spotlight on the Neglected Vessels.
Canale ML; Bisceglia I; Lestuzzi C; Parrini I;
Anticancer Res; 2019 Sep; 39(9):4619-4625. PubMed ID: 31519559
[TBL] [Abstract][Full Text] [Related]
9. Current perspectives in the treatment of thrombotic disorders.
Drouet L; Caen JP
Semin Thromb Hemost; 1989 Apr; 15(2):111-22. PubMed ID: 2665082
[TBL] [Abstract][Full Text] [Related]
10. Cancer and arterial thrombosis: therapeutic options.
Cheong MA; Leader A
Res Pract Thromb Haemost; 2024 Mar; 8(3):102393. PubMed ID: 38660456
[TBL] [Abstract][Full Text] [Related]
11. The prothrombotic state in cancer: pathogenic mechanisms.
De Cicco M
Crit Rev Oncol Hematol; 2004 Jun; 50(3):187-96. PubMed ID: 15182825
[TBL] [Abstract][Full Text] [Related]
12. Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue.
Herrmann J; Yang EH; Iliescu CA; Cilingiroglu M; Charitakis K; Hakeem A; Toutouzas K; Leesar MA; Grines CL; Marmagkiolis K
Circulation; 2016 Mar; 133(13):1272-89. PubMed ID: 27022039
[TBL] [Abstract][Full Text] [Related]
13. Vascular Complications of Cancer Chemotherapy.
Cameron AC; Touyz RM; Lang NN
Can J Cardiol; 2016 Jul; 32(7):852-62. PubMed ID: 26968393
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapeutic Agents and the Risk of Ischemia and Arterial Thrombosis.
Hassan SA; Palaskas N; Kim P; Iliescu C; Lopez-Mattei J; Mouhayar E; Mougdil R; Thompson K; Banchs J; Yusuf SW
Curr Atheroscler Rep; 2018 Feb; 20(2):10. PubMed ID: 29423705
[TBL] [Abstract][Full Text] [Related]
15. Cancer associated thrombosis: risk factors and outcomes.
Eichinger S
Thromb Res; 2016 Apr; 140 Suppl 1():S12-7. PubMed ID: 27067965
[TBL] [Abstract][Full Text] [Related]
16. Arterial thrombotic events and acute coronary syndromes with cancer drugs: are growth factors the missed link?: what both cardiologist and oncologist should know about novel angiogenesis inhibitors.
Conti E; Romiti A; Musumeci MB; Passerini J; Zezza L; Mastromarino V; D'Antonio C; Marchetti P; Paneni F; Autore C; Volpe M
Int J Cardiol; 2013 Sep; 167(6):2421-9. PubMed ID: 23414744
[TBL] [Abstract][Full Text] [Related]
17. Low-molecular-weight heparin in thrombosis and cancer.
Mousa SA
Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():25-30. PubMed ID: 15085463
[TBL] [Abstract][Full Text] [Related]
18. Vascular toxicities with VEGF inhibitor therapies-focus on hypertension and arterial thrombotic events.
Touyz RM; Herrmann SMS; Herrmann J
J Am Soc Hypertens; 2018 Jun; 12(6):409-425. PubMed ID: 29703600
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic therapy and progression of coronary artery disease. Antiplatelet versus antithrombins.
Chesebro JH; Webster MW; Zoldhelyi P; Roche PC; Badimon L; Badimon JJ
Circulation; 1992 Dec; 86(6 Suppl):III100-10. PubMed ID: 1424043
[TBL] [Abstract][Full Text] [Related]
20. Cancer and thrombosis revisited.
Hoffman R; Haim N; Brenner B
Blood Rev; 2001 Jun; 15(2):61-7. PubMed ID: 11409906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
